In this episode of ATTD 2026 Conference Catch-Up, we dive into Real Life Use of Continuous Glucose Monitoring (CGM), featuring an in-depth exploration of CGM's expanding role in diabetes management across various patient populations. Join us as we summarize key takeaways from these thought-provoking presentations: CGM Frequency Use in Type 2 Diabetes — Prof. Satish Garg CGM for Prediabetes — Dr. Viral N Shah CGM in Individuals Without Diabetes — Dr. Smadar Shilo Adapting CGM Reports for The Use in Real Life — Dr. Richard M. Bergenstal This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the latest CGM applications, offering insights into real-world utilization, practical reporting, and implications for a broader range of patients. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related